SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp selloff in large-cap technology stocks, amid disappointing earnings and outlooks and concerns that heavy AI investment may not pay off, has pressured QQQ. Traders are split between treating the decline as an oversold buying opportunity and expecting further losses, with some also citing possible forced selling and margin calls.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 76,874.98691422 USD and is down -4.82 over the last 24 hours. It is currently trading on 12773 active market(s) with $58,826,736,014.03 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoin is under pressure amid a reported major Binance security breach, which has raised concerns about exchange safety and triggered selling across crypto markets. Traders disagree on whether the drop signals further downside and withdrawal-related stress or is an overreaction, since the breach involved an exchange rather than Bitcoins protocol.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTXs breakout to a fresh 52-week high is drawing attention ahead of its expected Q3 earnings, with traders also pointing to BRIUMVIs sales growth and possible short covering. Buyout talk is fueling speculation, but some traders attribute the rally to earnings expectations rather than a potential deal, which the company has not confirmed.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas CFO warning that DefenCaths post-TDAPA Medicare add-on reimbursement could decline sharply after Q1 2027 is fueling concern about pricing and revenue, alongside CRMDs steep selloff. Traders debate whether the warning signals a real commercial setback or is preliminary, DaVita-specific modeling; some argue CMS estimates point to a less severe outcome and call the reaction excessive.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Updated Lifileucel lung-cancer dataan overall response rate near 25% and a much higher response rate in a retrospectively identified biomarker subgrouptriggered a sharp repricing amid concerns about durability, the smaller target population, and the path and timing to FDA filing. Traders are split between criticizing managements communication and seeing the subgroup results as a promising precision-treatment signal, with some calling the selloff excessive.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp semiconductor-sector selloff, intensified by Intels weak outlook tied to sluggish PC demand and high memory costs, has hammered SOXLs 3 leveraged exposure. Traders are split between buying the steep drop on continued AI and chip-demand expectations and warning that technical weakness, leveraged volatility, and further losses may persist.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels weak fourth-quarter outlook after its quarterly report, amid soft PC demand and manufacturing constraints, sparked a sharp selloff and analyst downgrades. Traders are divided between calling the drop an oversold buying opportunity and expecting further losses, with some also citing broader weakness in AI and tech stocks.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum is in focus amid reports of advanced Marvell takeover talks, but the deal remains unconfirmed and traders are debating whether an all-stock offer with limited premium would benefit LITE shareholders. The debate is compounded by a sharp selloff across AI and optical stocks: some traders see a buying opportunity tied to strong data-center demand, while others question the deals financing and the sectors outlook.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technologys newly disclosed convertible-note financing and proposed increase in authorized shares have put potential dilution at the center of the discussion, amid a sharp selloff. Critics say the terms and managements communication undermine shareholder confidence, while some investors argue the capital is needed to fund data-center expansion; broader weakness in AI stocks is also cited as a headwind.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff ahead of its quarterly earnings report, alongside analyst price-target cuts and concerns about advertising growth and competition, is the dominant topic. Traders disagree on whether the decline is an overdone valuation reset or a warning of weaker results, while weakness in ad-tech peers adds to caution.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Instinct Bio Technical Co. Holdings, Inc. is an integrated regenerative medicine and longevity company focused on research, manufacturing, and commercialization of regenerative health technologies. It develops stem cell-derived products, wellness solutions, and advanced skincare products. The company was founded in 2017 is headquartered in Tokyo Japan.

Instinct Bio Technical Company Holdings Inc.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

Biotech Acquisition Co - Ordinary Shares - Class A

$BIOT This seems unfairly beaten down...earnings look ok. Is there something I'm missing? Bad timing with market downturn?

NealioSpace

$BIOT this stock also has a 4m float with no approved r/s sitting at its 52 week low👀👀 Once the news drops this one can run 100/300% easy! Get in early before it’s to late patience is key here!!$LNKS $MNDR $YMAT $SDST

PriceActionSociety

$BIOT pending news this one will go parabolic once the news drops!! Everyone will be chasing once it’s already up 30%

$BIOT I feel like they may run this after hours, now that they knocked people out with new intra-day lows

sk7887

$BIOT perking to highs AH's, we may see a gap up in the AM...chart says a bigger move is coming.

$BIOT named CelSiege as its non-exclusive rep in Japan and China for IN01 cancer immunotherapy.

Feed

News

Sentiment

Fundamentals

Info

BIOT Biotech Acquisition Co - Ordinary Shares - Class A

Fundamentals

Latest BIOT News